CVS Health Corporation (CVS) Valuation — DCF & Advanced Analysis | MarketCI

CVS

Market Closed

CVS Health Corporation

NYSEHealthcare Medical - Healthcare Plans

300.00K employees

CEO: J. David Joyner

Founded: 1996

$98.32

+$0.00(+NaN%)

Market Cap

125.45B

Beta

0.62

52W Range

N/A

Dividend Yield

2.71%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

Comprehensive Valuation

In-depth valuation analysis including DCF scenarios and peer comparisons.

AI Insight: CVS Health appears significantly undervalued, with a current price at $100.68 versus a PERT-weighted fair value of $207.35 and a high-confidence upside of 105.9%. Monte Carlo analysis indicates zero downside below the current price, but extreme volatility (106.64% coefficient of variation) signals elevated risk. Financial health scores reveal poor profitability and growth, implying fundamental challenges amid valuation optimism.

Enhanced Football Field Analysis

Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore CVS

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples